TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

NCT05108870 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Human Papilloma Virus
HPV
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Head and Neck Cancer

Interventions

DRUG: HB-201
DRUG: HB-202
DRUG: Carboplatin
DRUG: Paclitaxel
PROCEDURE: Transoral Robotic Surgery

Sponsor

University of Chicago